Pages that link to "Q30354242"
Jump to navigation
Jump to search
The following pages link to Antiobesity pharmacotherapy: new drugs and emerging targets (Q30354242):
Displaying 50 items.
- Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum (Q26784022) (← links)
- Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences (Q28088815) (← links)
- Acetylshikonin from Zicao Prevents Obesity in Rats on a High-Fat Diet by Inhibiting Lipid Accumulation and Inducing Lipolysis (Q28552550) (← links)
- Role of glucagon-like peptide 1 receptor agonists in management of obesity (Q30248510) (← links)
- The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg (Q33750634) (← links)
- Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor (Q33838127) (← links)
- Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior (Q34501087) (← links)
- Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss (Q34637579) (← links)
- Congenital Malformations and Consequential Epidemiology. (Q35077898) (← links)
- Antiobesity strategy targets energy economy safeguards. (Q35399304) (← links)
- ThermoMouse: an in vivo model to identify modulators of UCP1 expression in brown adipose tissue (Q35481073) (← links)
- Lightening up a notch: Notch regulation of energy metabolism (Q35606440) (← links)
- Diacylglycerol Lipase α Knockout Mice Demonstrate Metabolic and Behavioral Phenotypes Similar to Those of Cannabinoid Receptor 1 Knockout Mice (Q35672654) (← links)
- Weight maintenance: challenges, tools and strategies for primary care physicians (Q35816619) (← links)
- Targeting metabolic disorders by natural products (Q35830892) (← links)
- Endocrine disruptors alter social behaviors and indirectly influence social hierarchies via changes in body weight. (Q35913778) (← links)
- A single oral dose of a polyglucosamine influences the bioavailability of [9-(14)C]-Oleic acid in adult female Göttingen minipigs (Q35962039) (← links)
- Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review (Q36206061) (← links)
- Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids (Q37102291) (← links)
- Treating epilepsy in the setting of medical comorbidities (Q38214818) (← links)
- Ghrelin receptor modulators: a patent review (2011 - 2014). (Q38232345) (← links)
- New perspectives on the development of antiobesity drugs (Q38397340) (← links)
- Nitric Oxide Regulates Skeletal Muscle Fatigue, Fiber Type, Microtubule Organization, and Mitochondrial ATP Synthesis Efficiency Through cGMP-Dependent Mechanisms (Q38412804) (← links)
- TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway (Q38435784) (← links)
- Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles (Q38758765) (← links)
- Convertible visceral fat as a therapeutic target to curb obesity. (Q38769110) (← links)
- Drugs to treat obesity: do they work? (Q38800281) (← links)
- Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity. (Q38820528) (← links)
- Effect of lorcaserin on glycemic parameters in patients with type 2 diabetes mellitus. (Q38874390) (← links)
- Chemoprevention of obesity by dietary natural compounds targeting mitochondrial regulation. (Q39012540) (← links)
- Emerging drugs for the treatment of obesity. (Q39031756) (← links)
- The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. (Q39666490) (← links)
- High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice (Q42709946) (← links)
- Progress and challenges in anti-obesity pharmacotherapy (Q43076027) (← links)
- Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide-mediated appetite control in amphetamine-treated rats. (Q47320464) (← links)
- Type 2 Diabetes: Progress Made but Still a Long Road to Travel to Reduce Disease Burden (Q47409034) (← links)
- Phentermine plus topiramate for weight reduction: more tolerable and effective? (Q47412106) (← links)
- Curcumin suppresses Notch‑1 signaling: Improvements in fatty liver and insulin resistance in rats (Q47426820) (← links)
- A Pilot Study Measuring The Novel Satiety Hormone, Pro-Uroguanylin, In Adolescents With And Without Obesity (Q47587497) (← links)
- Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice. (Q47618753) (← links)
- Molecular insights provide the critical path to disease mitigation (Q48384103) (← links)
- Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors. (Q52680710) (← links)
- Obesity management in Prader-Willi syndrome: current perspectives (Q57483607) (← links)
- Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue (Q57809886) (← links)
- Effects of Polyphenols on Thermogenesis and Mitochondrial Biogenesis (Q58742455) (← links)
- Role or Synergistic Interaction of Adenosine and Vitamin D3 Alongside High-Intensity Interval Training and Isocaloric Moderate Intensity Training on Metabolic Parameters: Protocol for an Experimental Study (Q64238937) (← links)
- Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease (Q64268252) (← links)
- We are not in Kansas anymore: The unfamiliar landscape of NASH (Q86697831) (← links)
- Ginsenoside Rg3 Induces Browning of 3T3-L1 Adipocytes by Activating AMPK Signaling (Q89658241) (← links)
- New Era: Endoscopic treatment options in obesity-a paradigm shift (Q90136069) (← links)